Unravelling a Mechanism of Group 2 Innate Lymphoid Immune Cell Development

Group 2 innate lymphoid cells (ILC2s) of the immune system are involved in allergic diseases. But currently, therapy targeting ILC2s is not available. Now, however, in an interesting study, researchers have identified a novel mechanism of ILC2 development. The researchers used single-cell RNA sequencing to discover regulatory regions in the genome that are associated with ILC2 development. These findings can help develop treatment strategies for allergic diseases.